tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Kostas Biliouris, 10 are a HOLD (32.26%), 21 are a BUY (67.74%).
Analyst Kostas Biliouris works at BMO with a stock forecast success ratio of 21.82% fulfilled within 84.45 days on average.
Kostas Biliouris’s has documented 59 price targets and ratings displayed on 11 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on CNTA, Centessa Pharmaceuticals PLC ADR at 01-Apr-2024.
Analyst best performing recommendations are on BEAM (BEAM THERAPEUTICS ).
The best stock recommendation documented was for BEAM (BEAM THERAPEUTICS ) at 7/18/2022. The price target of $61 was fulfilled within 1 day with a profit of $2.99 (5.15%) receiving and performance score of 51.54.
Average potential price target upside
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
57
$34.26 (150.66%)
48
2 days ago
3/6 (50%)
$33.53 (142.86%)
153
Buy
57
$34.26 (150.66%)
66
29 days ago
2/4 (50%)
$23.04 (67.84%)
4
Hold
42
$19.26 (84.70%)
26
1 months 28 days ago
7/7 (100%)
$-1.61 (-3.69%)
164
Hold
35
$12.26 (53.91%)
42
1 months 28 days ago
3/3 (100%)
$-8.61 (-19.74%)
114
Buy
40
$17.26 (75.90%)
75
2 months 27 days ago
3/5 (60%)
$11.71 (41.39%)
237
Which stock is Kostas Biliouris is most bullish on?
Which stock is Kostas Biliouris is most reserved on?
What Year was the first public recommendation made by Kostas Biliouris?
